PO-1653: Dosimetric effects of interfractional variations in prostate cancer radiotherapy. (November 2020) - Bostel, T.; Sachpazidis, I.; Splinter, M.; Bougatf, N.; Fechter, T.; Zamboglou, C.; Jäkel, O.; Huber, P.; Baltas, D.; Debus, J.; Nicolay, N.